Ignite Creation Date:
2025-12-24 @ 5:54 PM
Ignite Modification Date:
2025-12-26 @ 3:12 AM
Study NCT ID:
NCT03137368
Status:
UNKNOWN
Last Update Posted:
2018-10-31
First Post:
2017-04-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate Exemestane Tablets Combined With Ovarian Function Suppression/Ablation in Treatment of Premenopausal Breast Cancer Patients With CYP2D6*10 Mutations （STEP）
Sponsor:
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-08-09
Start Date Type:
ACTUAL
Primary Completion Date:
2023-10-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-10-30
Completion Date Type:
ESTIMATED
First Submit Date:
2017-04-24
First Submit QC Date:
None
Study First Post Date:
2017-05-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-28
Last Update Post Date:
2018-10-31
Last Update Post Date Type:
ACTUAL